Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Center as well as any non-oncology infusion needs of patients at UCSF. The treatments include but are not limited to chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and electrolyte
-
immunotherapies, and how metabolic interventions can be aimed at improving immunotherapy outcomes. The program will be potentially complementary and collaborative with current strengths in the School of Medicine
-
by identifying and validating therapeutic targets for treatment and by developing robust protocols for in vitro production of clinical-grade blood cells for adoptive cancer immunotherapies
-
of mortality worldwide, claiming nearly ten million lives each year. One promising treatment is cancer immunotherapy using mRNA encapsulated in lipid vesicles, which facilitate efficient drug transport
-
Center as well as any non-oncology infusion needs of patients at UCSF. The treatments include but are not limited to chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and electrolyte
-
Professor (research track) position will focus on providing high-level expertise in cancer biology, immunology, immunotherapy, bioinformatics, formulations and its associated theories, concepts, methods, and
-
Work Schedule: Monday – Friday, 8 a.m. – 5 p.m. Summary The Systems Onco-Immunology Lab (SOIL) https://www.bcm.edu/departments/surgery/research/systems-onco-immunology-lab at Michael E. DeBakey
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
to apply Website https://rrhh.ffis.es/rrhh/ofertaEmpleo.jsf?id=1946 Requirements Research FieldOtherEducation LevelPhD or equivalent Skills/Qualifications Development of somatic cell therapy: Preclinical
-
for tumor diseases, such as immunotherapy, radiation therapy, chemotherapy, and hormone therapy. Max Levin’s research group studies the connection between immune-related adverse events and treatment efficacy